Literature DB >> 1536782

Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice.

A Gilhar1, T Pillar, B Assay, M David.   

Abstract

We have previously demonstrated regrowth of hair in scalp skin grafts taken from patients with alopecia areata (AA) and alopecia universalis (AU) following engraftment on to nude mice. This present study was to determine whether serum from patients with AA and AU, has a role in the process of hair loss and the role of antibodies and complement. Forty mice were grafted with transplants obtained from seven patients. One group of the grafted mice was given patients' serum and another group normal serum. The mice were treated topically with cyclosporin (CyA), or olive oil. Hair growth was noted in most grafts and intravenous injections of serum did not prevent or inhibit this process. Immunofluorescence studies before grafting showed deposition of immunoglobulins and complement in hair follicles in both normal and affected scalp skin, but a more striking deposition was noted in the affected skin. Deposition of immunoreactants after grafting was observed only after the injection of serum from the patients but not with normal serum. Thus the sera from patients with AA or AU, when injected into nude mice with hair transplants from the scalp skin of patients with these disorders, does not alter the hair growth despite deposition of immunoreactants around the hair follicles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536782     DOI: 10.1111/j.1365-2133.1992.tb07815.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

Review 1.  Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Authors:  Amos Gilhar; Ralf Paus; Richard S Kalish
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 2.  [Alopecia areata. Clinical aspects, pathogenesis and rational therapy of a T-cell-induced autoimmune disease].

Authors:  P Freyschmidt-Paul; R Happle; R Hoffmann
Journal:  Hautarzt       Date:  2003-08       Impact factor: 0.751

Review 3.  Does Complement Have a Role in the Pathogenesis of Alopecia Areata?

Authors:  Margit L W Juhász; Natasha Atanaskova Mesinkovska
Journal:  Skin Appendage Disord       Date:  2018-03-22

4.  Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.

Authors:  A Gilhar; Y Ullmann; T Berkutzki; B Assy; R S Kalish
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 5.  The current state of knowledge of the immune ecosystem in alopecia areata.

Authors:  Samuel J Connell; Ali Jabbari
Journal:  Autoimmun Rev       Date:  2022-02-10       Impact factor: 17.390

Review 6.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

7.  Androgenic alopecia is associated with less dietary soy, lower [corrected] blood vanadium and rs1160312 1 polymorphism in Taiwanese communities.

Authors:  Ching-Huang Lai; Nain-Feng Chu; Chi-Wen Chang; Shu-Li Wang; Hsin-Chou Yang; Chi-Ming Chu; Chu-Ting Chang; Ming-Huang Lin; Wu-Chien Chien; Sui-Lung Su; Yu-Ching Chou; Kang-Hua Chen; Wei-Ming Wang; Saou-Hsing Liou
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

Review 8.  Immunology of alopecia areata.

Authors:  Marta Żeberkiewicz; Lidia Rudnicka; Jacek Malejczyk
Journal:  Cent Eur J Immunol       Date:  2020-11-01       Impact factor: 2.085

Review 9.  Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?

Authors:  R Paus; A Slominski; B M Czarnetzki
Journal:  Yale J Biol Med       Date:  1993 Nov-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.